WO2005027872A3 - Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof - Google Patents

Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof Download PDF

Info

Publication number
WO2005027872A3
WO2005027872A3 PCT/US2004/017417 US2004017417W WO2005027872A3 WO 2005027872 A3 WO2005027872 A3 WO 2005027872A3 US 2004017417 W US2004017417 W US 2004017417W WO 2005027872 A3 WO2005027872 A3 WO 2005027872A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
making
pathogenic microorganisms
inactivating pathogenic
Prior art date
Application number
PCT/US2004/017417
Other languages
French (fr)
Other versions
WO2005027872A2 (en
Inventor
James R Baker
Ted C Annis
Tarek Hamouda
Linda Vengroff
Original Assignee
Nanobio Corp
James R Baker
Ted C Annis
Tarek Hamouda
Linda Vengroff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobio Corp, James R Baker, Ted C Annis, Tarek Hamouda, Linda Vengroff filed Critical Nanobio Corp
Priority to EP04809431A priority Critical patent/EP1633322A2/en
Priority to CA2528095A priority patent/CA2528095C/en
Priority to AU2004273779A priority patent/AU2004273779B2/en
Publication of WO2005027872A2 publication Critical patent/WO2005027872A2/en
Publication of WO2005027872A3 publication Critical patent/WO2005027872A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Abstract

Nanoemulsion compositions with low toxicity that demonstrate broad spectrum inactivation of microorganisms or prevention of diseases are described. The nanoemulsions contain an aqueous phase, an oil phase comprising an oil and an organic solvent, and one or more surfactants. Methods of making nanoemulsions and inactivating pathogenic microorganisms are also provided.
PCT/US2004/017417 2003-06-04 2004-06-03 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof WO2005027872A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP04809431A EP1633322A2 (en) 2003-06-04 2004-06-03 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
CA2528095A CA2528095C (en) 2003-06-04 2004-06-03 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
AU2004273779A AU2004273779B2 (en) 2003-06-04 2004-06-03 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45763303P 2003-06-04 2003-06-04
US60/475,633 2003-06-04

Publications (2)

Publication Number Publication Date
WO2005027872A2 WO2005027872A2 (en) 2005-03-31
WO2005027872A3 true WO2005027872A3 (en) 2006-03-09

Family

ID=34375188

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/017417 WO2005027872A2 (en) 2003-06-04 2004-06-03 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof

Country Status (4)

Country Link
EP (1) EP1633322A2 (en)
AU (1) AU2004273779B2 (en)
CA (1) CA2528095C (en)
WO (1) WO2005027872A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9259407B2 (en) 2008-09-26 2016-02-16 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
JP7266038B2 (en) 2018-01-23 2023-04-27 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Transparent nanoemulsion containing laurin oil
JP7309720B2 (en) 2018-01-23 2023-07-18 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Method for producing transparent nanoemulsion containing laurin oil

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763663B2 (en) 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
WO2004100890A2 (en) 2003-05-09 2004-11-25 The Trustees Of Columbia University In The City Of New York Rage g82s-related methods and compositions for treating inflammatory disorders
AU2016244292A1 (en) * 2005-07-18 2016-11-03 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
AU2006346369B2 (en) * 2005-07-18 2013-02-21 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
EP1951200A2 (en) 2005-08-09 2008-08-06 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
ES2710781T3 (en) 2005-12-01 2019-04-26 Univ Massachusetts Lowell Nanoemulsions of botulinum
AU2007240983A1 (en) * 2006-04-07 2007-11-01 Novavax, Inc. Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US9839685B2 (en) 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
WO2007120860A2 (en) * 2006-04-13 2007-10-25 The Regents Of The University Of Michigan Nanoemulsion vaccines
FR2907012B1 (en) 2006-10-12 2012-09-21 Galderma Sa DERMATOLOGICAL COMPOSITION COMPRISING AVERMECTIN NANOCAPSULES, PROCESS FOR PREPARING THE SAME AND USE THEREOF
MX2009005727A (en) 2006-12-01 2009-08-27 Anterios Inc Amphiphilic entity nanoparticles.
WO2008140594A2 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
DE102007007698A1 (en) * 2007-02-09 2008-08-21 Exner, Heinrich, Dr. Use of a highly emulsified silicone oil emulsion (HSE) for the manufacture of a medicament
CN101765423B (en) 2007-05-31 2014-08-06 安特里奥公司 Nucleic acid nanoparticles and uses therefor
BRPI0705564B8 (en) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria continuous liquid crystal type system containing co-solvents carrying sparingly soluble substances in water, its process of obtaining and its uses
US9144606B2 (en) 2008-04-21 2015-09-29 Nanobio Corporation Nanoemulsion influenza vaccine
CA2722445A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections
WO2009132343A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating onchomycosis
AU2009248810B2 (en) 2008-05-23 2013-12-05 The Regents Of The University Of Michigan Nanoemulsion vaccines
US20110212157A1 (en) 2008-06-26 2011-09-01 Anterios, Inc. Dermal delivery
BRPI0918685A2 (en) * 2008-12-31 2015-12-01 Sunev Pharma Solution Ltd topical formulation and process of preparing a topical formulation
US9345660B2 (en) * 2009-06-05 2016-05-24 Sunev Pharma Solution Limited Micro-emulsions for the treatment of rheumatic disorders
CL2012001399A1 (en) 2009-12-03 2013-03-08 Novartis Ag Method to manufacture adjuvant for vaccine (oil / water emulsion with squalene, polysorbate 80 and sorbitan trioleate), which comprises (i) forming the first emulsion in a homogenizer from one container to another to form a second emulsion, (ii) and microfluidizing the first emulsion to form second emulsion.
DE102009056884B4 (en) 2009-12-03 2021-03-18 Novartis Ag Vaccine Adjuvants and Improved Methods for Making Same
WO2011067673A2 (en) 2009-12-03 2011-06-09 Novartis Ag Circulation of components during homogenization of emulsions
CA2782650C (en) † 2009-12-03 2014-02-04 Novartis Ag Arranging interaction and back pressure chambers for microfluidization
US10213383B2 (en) 2009-12-03 2019-02-26 Novartis Ag Hydrophilic filtration during manufacture of vaccine adjuvants
DE102009056871A1 (en) 2009-12-03 2011-06-22 Novartis AG, 4056 Vaccine adjuvants and improved methods of making the same
AU2013213678B2 (en) * 2009-12-03 2016-06-23 Novartis Ag Arranging interaction and back pressure chambers for microfluidization
DE102009056883B4 (en) 2009-12-03 2012-08-16 Novartis Ag Vaccine adjuvants and improved methods of making the same
DE202010004750U1 (en) * 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmaceutical and / or cosmetic composition for the treatment of the skin
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
WO2014206857A1 (en) * 2013-06-28 2014-12-31 Universitat Autonoma De Barcelona Oil-in-water formulations of mycobacterium and uses thereof
BR112016021700A2 (en) * 2014-03-21 2017-10-03 Univ Florida USE OF ALDEHYDES FORMULATED WITH NANOPARTICLES AND/OR NANOEMULSIONS TO IMPROVE RESISTANCE TO PLANT DISEASES CAUSED BY LIBERIBACTERS
CN104274405A (en) * 2014-10-21 2015-01-14 河南牧翔动物药业有限公司 Oil-in-water type compound ceftiofur nanoemulsion antimicrobial medicament
KR20170113568A (en) * 2015-02-06 2017-10-12 알.피.쉐러 테크놀러지즈 엘엘씨 Preparation of an oil-in-water emulsion for polymer-stabilized pharmaceutical preparations
EP4219724A3 (en) 2016-08-23 2023-09-27 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
CN106924730B (en) * 2017-02-14 2019-11-08 商丘美兰生物工程有限公司 Porcine pseudorabies virus Aloe Vera Gel nano emulsion adjuvant inactivated vaccine and preparation method thereof
CA3168055A1 (en) 2020-02-21 2021-08-26 Emmanuel John Simons Compositions and methods for treating non-age-associated hearing impairment in a human subject
CN113662006B (en) * 2021-06-30 2022-05-20 南京凯创协同纳米技术有限公司 Preparation method of micro-nano zinc capable of killing bacteria and inactivating viruses
WO2024005601A1 (en) * 2022-06-30 2024-01-04 씨제이제일제당(주) Medical composition

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0448925A (en) * 1990-06-15 1992-02-18 Kanebo Ltd Fine emulsion composition
WO2001049296A1 (en) * 1999-12-30 2001-07-12 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
WO2002051390A2 (en) * 2000-12-27 2002-07-04 Ares Trading S.A. Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
US20030194412A1 (en) * 2001-06-05 2003-10-16 The Regents Of The University Of Michigan Nanoemulsion vaccines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0448925A (en) * 1990-06-15 1992-02-18 Kanebo Ltd Fine emulsion composition
WO2001049296A1 (en) * 1999-12-30 2001-07-12 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
WO2002051390A2 (en) * 2000-12-27 2002-07-04 Ares Trading S.A. Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
US20030194412A1 (en) * 2001-06-05 2003-10-16 The Regents Of The University Of Michigan Nanoemulsion vaccines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 016, no. 234 (C - 0945) 29 May 1992 (1992-05-29) *
See also references of EP1633322A2 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US9259407B2 (en) 2008-09-26 2016-02-16 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
JP7266038B2 (en) 2018-01-23 2023-04-27 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Transparent nanoemulsion containing laurin oil
JP7309720B2 (en) 2018-01-23 2023-07-18 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Method for producing transparent nanoemulsion containing laurin oil

Also Published As

Publication number Publication date
EP1633322A2 (en) 2006-03-15
CA2528095C (en) 2014-10-14
AU2004273779B2 (en) 2009-10-22
AU2004273779A1 (en) 2005-03-31
CA2528095A1 (en) 2005-03-31
WO2005027872A2 (en) 2005-03-31
AU2004273779A2 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
WO2005027872A3 (en) Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
WO2008051186A3 (en) Nanoemulsion containing compositions having ant i -inflammatory activity
WO2005009943A3 (en) Substituted tetracycline compounds
WO2006047671A3 (en) 4-aminotetracyclines and methods of use thereof
WO2004098494A3 (en) Compounds, compositions, and methods
EP2284164A3 (en) Substituted tetracycline compounds
WO2004103960A3 (en) Compounds and uses thereof
WO2005066151A3 (en) Histone deacetylase inhibitors
WO2006099192A3 (en) Stable organic peroxide compositions
WO2007133290A8 (en) Anti-ox40l antibodies and methods using same
WO2007005471A3 (en) Stable organic peroxide compositions
WO2006083936A3 (en) Anti-ephb2 antibodies and methods using same
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
WO2004014893A3 (en) Antimicrobial aza-bicyclic derivates, their compositions and uses
MX256798B (en) Dispersions of polymers in organic medium, and compositions comprising them.
WO2007011741A3 (en) Stable organic devices
MX2008001597A (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment.
WO2008048121A3 (en) Macrocyclic cysteine protease inhibitors and compositions thereof
WO2006097617A3 (en) Novel dihydropyrimidine derivatives and their use as anti-cancer agents
WO2005035537A3 (en) Substituted tricyclic heterocycles and their uses
WO2006029398A8 (en) All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use
WO2005051083A3 (en) Molluscicidal and anti-barnacle compounds
WO2002080855A3 (en) Methods and compounds for decreasing cell toxicity or death
WO2004091513A3 (en) 9-aminomethyl substituted minocycline compounds
WO2004034961A3 (en) Antimicrobial agents and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NA NI NO NZ PG PH PL PT RO RU SC SD SE SG SK SY TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IT MC NL PL PT RO SE SI SK TR BF CF CG CI CM GA GN GQ GW ML MR SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2528095

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004273779

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004809431

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004273779

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004809431

Country of ref document: EP